These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15931713)

  • 21. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
    Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
    J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The year's new drugs.
    Graul AI
    Drug News Perspect; 2003; 16(1):22-39. PubMed ID: 12682669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 24. The present volume is base on the "Integrating Systems Approaches into Pharmaceutical Sciences" conference held in Basel in 2007. Preface.
    Goryanin I; Lebedeva G
    Eur J Pharm Sci; 2009 Jan; 36(1):1-3. PubMed ID: 19038334
    [No Abstract]   [Full Text] [Related]  

  • 25. Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus.
    Schiapparelli L; Simón AM; Del Río J; Frechilla D
    Neuropharmacology; 2006 Jun; 50(7):897-907. PubMed ID: 16620883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effects of the 5HT1A antagonists MM-77 and WAY-100635 on the mouse isolated vasa deferentia.
    Arkle MJ; Arkle S; Ebenezer IS
    Auton Autacoid Pharmacol; 2005 Jul; 25(3):121-8. PubMed ID: 15955032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug metabolism and drug interaction of anxiolytics].
    Uchimura N; Etou Y
    Ryoikibetsu Shokogun Shirizu; 2003; (38):612-6. PubMed ID: 12877062
    [No Abstract]   [Full Text] [Related]  

  • 29. Biosurfactants: potential applications in medicine.
    Rodrigues L; Banat IM; Teixeira J; Oliveira R
    J Antimicrob Chemother; 2006 Apr; 57(4):609-18. PubMed ID: 16469849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
    Heightman TD; Gaster LM; Pardoe SL; Pilleux JP; Hadley MS; Middlemiss DN; Price GW; Roberts C; Scott CM; Watson JM; Gordon LJ; Holland VA; Powles J; Riley GJ; Stean TO; Trail BK; Upton N; Austin NE; Ayrton AD; Coleman T; Cutler L
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4370-4. PubMed ID: 16039851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation.
    Horiuchi J; McDowall LM; Dampney RA
    Auton Neurosci; 2008 Nov; 142(1-2):71-6. PubMed ID: 18667366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
    Perrone R; Berardi F; Colabufo NA; Lacivita E; Larizza C; Leopoldo M; Tortorella V
    J Pharm Pharmacol; 2005 Oct; 57(10):1319-27. PubMed ID: 16259761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivating for knowledge: potential pharmacological agents in tick saliva.
    Hovius JW; Levi M; Fikrig E
    PLoS Med; 2008 Feb; 5(2):e43. PubMed ID: 18271624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From cocaine to innovative antiemetics. The medicinal chemistry of 5-ht3 receptor antagonists].
    Zettl H; Schubert-Zsilavecz M; Siebert CD
    Pharm Unserer Zeit; 2007; 36(5):354-61. PubMed ID: 17722162
    [No Abstract]   [Full Text] [Related]  

  • 35. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
    Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
    Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress.
    Bambico FR; Nguyen NT; Gobbi G
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):215-28. PubMed ID: 19147333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioactive and antibacterial terpenoids from some Salvia species.
    Ulubelen A
    Phytochemistry; 2003 Sep; 64(2):395-9. PubMed ID: 12943755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in drug development. 14].
    Délenk-Heydenreich K; Henkler G; Keller U; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1981 Nov; 36(11):723-48. PubMed ID: 7033997
    [No Abstract]   [Full Text] [Related]  

  • 39. New triorganotin (IV) derivatives of dipeptides as models for metal-protein interactions: synthesis, structural characterization and biological studies.
    Nath M; Pokharia S; Eng G; Song X; Kumar A
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Jan; 63(1):66-75. PubMed ID: 15950528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2006 Mar; 14(5):1391-402. PubMed ID: 16266808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.